{"nct_id":"NCT06504394","title":"A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-10-14","start_date_type":"ACTUAL","primary_completion_date":"2028-11-08","primary_completion_date_type":"ESTIMATED","completion_date":"2028-11-08","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}